Replies to post #760806 on NorthWest Biotherapeutics Inc (NWBO)

[SkyLimit2022]

marty,

Thanks for sharing your perspective on the influence of the JAMA Oncology peer review. I would add that Dr. Ashkan also has considerable influence with the MHRA—his work is world-renowned and he is highly respected, especially in the UK. He led the P3 trial in Europe and currently oversees the ongoing Specials Program for DCVax-L in the UK. The MHRA continues to support the use of DCVax-L under the Specials Program, and a patient treated through the program was the subject of a peer-reviewed case study.

In April 2025, NICE published a note referencing its ongoing communication with NWBO as they are awaiting completion of MHRA’s review of their voluminous MAA submission:

“NICE is continuing to liaise with Northwest Biotherapeutics. The company reports that it is still fully occupied and engaged in the Marketing Authorisation Application (MAA) process with the MHRA.”

https://www.nice.org.uk/guidance/indevelopment/gid-ta10143




King’s College London maintains established connections with the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), and Dr. Ashkan holds a prominent position at King’s!




“His work on brain cancer vaccines received the top presentation award by the British Neuro-Oncology Society in 2022 and promises to impact the care of patients with brain tumours worldwide.”

Consultant Neurosurgeon at @KingsCollegeNHS, Professor Keyoumars Ashkan, receives an MBE for services to neurosurgery.
 
In 2020, he removed patient Dagmar's brain tumour while she played her violin throughout the surgery. 👇pic.twitter.com/H2Z4LZic0h

— NHS London (@NHSEnglandLDN) December 31, 2024

https://thejns.org/caselessons/view/journals/j-neurosurg-case-lessons/8/2/article-CASE24112.xml

https://www.kcl.ac.uk/news/professor-keyoumars-ashkan-awarded-mbe-in-kings-new-years-honours

https://www.bbc.com/news/uk-england-london-66378288

https://www.kch.nhs.uk/news/kings-team-wins-professional-excellence-award/

Congratulations to all the nominees and winners @TheSun Who Cares Wins awards, including Professor Keyoumars Ashkan, Consultant Neurosurgeon at King’s, who was a runner up in the Groundbreaking Pioneer category.#TeamKings @KensingtonRoyal @OfficialTM_3 @KingsNeuro pic.twitter.com/6qTnOfazAN

— King's College NHS (@KingsCollegeNHS) September 20, 2021

Congratulations to Professor Keyoumars Ashkan, a professor of neurosurgery at King's, who has been named UK Clinician of the Year by the @BrainTumourOrg. Find out more here: https://t.co/32b69Plheq #TeamKings pic.twitter.com/9no1BsnNqo

— King's College NHS (@KingsCollegeNHS) April 27, 2018

[norisknorewards]

"They" lmao

[norisknorewards]

Marty says " it would’ve been a straight-up rejection."

Marty also alleges he is a shareholder.

If you're a shareholder and you think the end result is 'straight up rejection' you're impo, probably not a credible poster to take notes from.

Sincerely,

A real shareholder of the company